# FDA Inspection 1297060 - Centaur Pharmaceuticals Private Limited - November 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/centaur-pharmaceuticals-private-limited/5f56015a-a081-49cb-bd90-789438dd52a9
Source feed: FDA_Inspections

> FDA Inspection 1297060 for Centaur Pharmaceuticals Private Limited on November 14, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1297060
- Company Name: Centaur Pharmaceuticals Private Limited
- Inspection Date: 2025-11-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1297060 - 2025-11-14](https://www.keypedia.com/records/fda_inspections/centaur-pharmaceuticals-private-limited/e5ced999-2847-4fe6-8db8-1737b2305dc9)

Company: https://www.keypedia.com/companies/centaur-pharmaceuticals-private-limited/429667f3-78f8-45f1-b2ac-da0509f3e48d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c